Fredric L. Coe to Humans
This is a "connection" page, showing publications Fredric L. Coe has written about Humans.
Connection Strength
1.137
-
Vitamin D and Parathyroid Hormone Levels in CKD. Am J Kidney Dis. 2023 01; 81(1):122-124.
Score: 0.027
-
Relative contributions of urine sulfate, titratable urine anion, and GI anion to net acid load and effects of age. Physiol Rep. 2021 05; 9(10):e14870.
Score: 0.025
-
Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1166-1173.
Score: 0.024
-
Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374.
Score: 0.023
-
A laboratory-based algorithm to predict future kidney function decline in older adults with reduced estimated glomerular filtration rate?. Clin Nephrol. 2019 Sep; 92(3):113-122.
Score: 0.022
-
Restoration of wall shear stress in the cephalic vein during extreme hemodynamics. J Med Eng Technol. 2018 Nov; 42(8):617-627.
Score: 0.022
-
Mechanism for higher urine pH in normal women compared with men. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F623-F629.
Score: 0.020
-
Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016 09; 12(9):519-33.
Score: 0.018
-
Increased Inlet Blood Flow Velocity Predicts Low Wall Shear Stress in the Cephalic Arch of Patients with Brachiocephalic Fistula Access. PLoS One. 2016; 11(4):e0152873.
Score: 0.018
-
Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77.
Score: 0.016
-
Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48.
Score: 0.015
-
Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Sep 15; 305(6):F853-60.
Score: 0.015
-
Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Aug 15; 305(4):F592-9.
Score: 0.015
-
Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant. 2012 Jul; 27(7):2847-53.
Score: 0.013
-
Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92.
Score: 0.013
-
"A sudden lift of wings": Poetry and prose about Alzheimer's disease. Perspect Biol Med. 2011; 54(1):106-14.
Score: 0.012
-
Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8.
Score: 0.012
-
Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010 Dec; 38(6):439-52.
Score: 0.012
-
Medicine. Stopping the stones. Science. 2010 Oct 15; 330(6002):325-6.
Score: 0.012
-
Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63.
Score: 0.012
-
Stones. A matter of doubt--how best to evaluate stone formers. Nat Rev Urol. 2010 Sep; 7(9):483-5.
Score: 0.012
-
Evidence for altered renal tubule function in idiopathic calcium stone formers. Urol Res. 2010 Aug; 38(4):263-9.
Score: 0.012
-
Plaque and deposits in nine human stone diseases. Urol Res. 2010 Aug; 38(4):239-47.
Score: 0.012
-
Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7.
Score: 0.012
-
Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60.
Score: 0.012
-
Does idiopathic hypercalciuria trigger calcium-sensing receptor-mediated protection from urinary supersaturation? J Am Soc Nephrol. 2009 Aug; 20(8):1657-9.
Score: 0.011
-
Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant. 2009 Jul; 24(7):2190-4.
Score: 0.011
-
Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46.
Score: 0.011
-
Nephrolithiasis. Prim Care. 2008 Jun; 35(2):369-91, vii.
Score: 0.010
-
New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008 Mar; 28(2):120-32.
Score: 0.010
-
Cephalic arch stenosis in patients with fistula access for hemodialysis: relationship to diabetes and thrombosis. Hemodial Int. 2008 Jan; 12(1):85-9.
Score: 0.010
-
Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007 Feb; 177(2):565-9.
Score: 0.009
-
Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75.
Score: 0.009
-
Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int. 2006 Oct; 70(8):1463-7.
Score: 0.009
-
Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603.
Score: 0.009
-
Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol. 2006 Sep; 291(3):F530-6.
Score: 0.009
-
Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6.
Score: 0.009
-
Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608.
Score: 0.009
-
Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90.
Score: 0.008
-
Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol. 2004 Nov-Dec; 232(1-2):137-43.
Score: 0.008
-
Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab. 2004 Oct; 89(10):4937-43.
Score: 0.008
-
Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4.
Score: 0.008
-
Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13.
Score: 0.008
-
Endoscopic renal papillary biopsies: a tissue retrieval technique for histological studies in patients with nephrolithiasis. J Urol. 2003 Dec; 170(6 Pt 1):2186-9.
Score: 0.008
-
Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023 12 01; 325(6):F811-F816.
Score: 0.007
-
A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023 07 19; 14(1):4140.
Score: 0.007
-
Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1059-1067.
Score: 0.007
-
Editorial: Something new about stones. J Urol. 2003 Feb; 169(2):478-9.
Score: 0.007
-
Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65.
Score: 0.007
-
Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
Score: 0.007
-
What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565.
Score: 0.007
-
Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6.
Score: 0.007
-
Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7.
Score: 0.007
-
Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis. J Endourol. 2022 05; 36(5):694-702.
Score: 0.007
-
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002 Apr; 167(4):1607-12.
Score: 0.007
-
Does a failure of crystal inhibition cause calcium renal stones? Nephron. 2002 Apr; 90(4):361-4.
Score: 0.007
-
Patient adherence to long-term medical treatment of kidney stones. J Urol. 2001 Dec; 166(6):2057-60.
Score: 0.007
-
Proportional reduction of urine supersaturation during nephrolithiasis treatment. J Urol. 2001 Oct; 166(4):1247-51.
Score: 0.006
-
Agreement of Food Records and 24-Hour Urine Studies in Clinical Practice. J Ren Nutr. 2022 01; 32(1):51-57.
Score: 0.006
-
Differences in urine volume and supersaturation in 2 physician networks. J Urol. 2001 Aug; 166(2):423-8.
Score: 0.006
-
Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J Urol. 2001 Aug; 166(2):688-93.
Score: 0.006
-
Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep. 2021 07; 9(13):e14943.
Score: 0.006
-
Clinical use of cystine supersaturation measurements. J Urol. 2000 Nov; 164(5):1481-5.
Score: 0.006
-
Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones. J Endourol. 2020 03; 34(3):385-393.
Score: 0.006
-
In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208.
Score: 0.006
-
Prevention of recurrent nephrolithiasis. Am Fam Physician. 1999 Nov 15; 60(8):2269-76.
Score: 0.006
-
A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta. 1999 Nov; 289(1-2):57-68.
Score: 0.006
-
Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999 Nov; 56(5):1879-85.
Score: 0.006
-
Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 1999 Oct; 56(4):1505-16.
Score: 0.006
-
Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 07 01; 317(7):F65-F72.
Score: 0.005
-
Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999 Apr; 161(4):1077-81.
Score: 0.005
-
Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 04; 33(4):337-342.
Score: 0.005
-
Beverages, diet, and prevention of kidney stones. Am J Kidney Dis. 1999 Feb; 33(2):398-400; discussion 401-3.
Score: 0.005
-
Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol. 1998 Nov; 160(5):1629-34.
Score: 0.005
-
Foscarnet crystal deposition and renal failure. Am J Kidney Dis. 1998 Sep; 32(3):519-20.
Score: 0.005
-
Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization. Am J Physiol. 1998 08; 275(2):F255-61.
Score: 0.005
-
Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242.
Score: 0.005
-
Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998 Jun; 159(6):1821-5.
Score: 0.005
-
Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
Score: 0.005
-
Renal stone disease in older adults. Clin Geriatr Med. 1998 May; 14(2):367-81.
Score: 0.005
-
Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol. 1998 Mar; 159(3):664-8.
Score: 0.005
-
Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8.
Score: 0.005
-
Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192.
Score: 0.005
-
Diet and calcium: the end of an era? Ann Intern Med. 1997 Apr 01; 126(7):553-5.
Score: 0.005
-
New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997 Apr; 12(4):522-33.
Score: 0.005
-
Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900.
Score: 0.005
-
"Felix Randal": a poem about medicine. Pharos Alpha Omega Alpha Honor Med Soc. 1997; 60(2):24-8.
Score: 0.005
-
Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90.
Score: 0.005
-
The financial effects of kidney stone prevention. Kidney Int. 1996 Nov; 50(5):1706-12.
Score: 0.005
-
Pathogenesis and treatment of calcium stones. Semin Nephrol. 1996 Sep; 16(5):398-411.
Score: 0.005
-
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016 Dec; 29(6):715-734.
Score: 0.005
-
Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1996 Apr; 7(4):602-7.
Score: 0.004
-
Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol. 2015 Oct 15; 16:163.
Score: 0.004
-
A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis. J Endourol. 2016 Jan; 30(1):122-7.
Score: 0.004
-
Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12.
Score: 0.004
-
Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92.
Score: 0.004
-
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1):63-70.
Score: 0.004
-
Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones. Am J Physiol Renal Physiol. 2015 Apr 15; 308(8):F938-49.
Score: 0.004
-
Idiopathic hypercalciuria: the contribution of Dr. Jacob Lemann, Jr. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S59-69.
Score: 0.004
-
Mechanisms of human kidney stone formation. Urolithiasis. 2015 Jan; 43 Suppl 1:19-32.
Score: 0.004
-
Micro-CT imaging of Randall's plaques. Urolithiasis. 2015 Jan; 43 Suppl 1:13-7.
Score: 0.004
-
An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int. 1994 Jun; 45(6):1722-30.
Score: 0.004
-
Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis. Acta Urol Belg. 1994 Jun; 62(2):25-9.
Score: 0.004
-
Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab. 1994; 20(6):378-84.
Score: 0.004
-
Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron. 1994; 67(4):414-8.
Score: 0.004
-
A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84.
Score: 0.004
-
Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013 Mar; 14(4):435-47.
Score: 0.004
-
The pathogenesis and treatment of kidney stones. N Engl J Med. 1992 Oct 15; 327(16):1141-52.
Score: 0.003
-
Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo. Cancer Res. 1992 Mar 15; 52(6):1573-9.
Score: 0.003
-
Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8.
Score: 0.003
-
Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int. 1992 Jan; 41(1):139-42.
Score: 0.003
-
Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol. 1991 Nov; 261(5 Pt 2):F824-30.
Score: 0.003
-
Inhibitors within the nephron. Am J Kidney Dis. 1991 Apr; 17(4):407-13.
Score: 0.003
-
Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol. 1991 Apr; 260(4 Pt 2):F569-78.
Score: 0.003
-
Isolation of nephrocalcin from kidney tissue of nine vertebrate species. Am J Physiol. 1991 Feb; 260(2 Pt 2):F243-8.
Score: 0.003
-
Hereditary aspects of calcium nephrolithiasis. Adv Nephrol Necker Hosp. 1991; 20:31-40.
Score: 0.003
-
Nephrocalcinosis: re-defined in the era of endourology. Urol Res. 2010 Dec; 38(6):421-7.
Score: 0.003
-
Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990 Oct; 38(4):625-31.
Score: 0.003
-
Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate. Hemodial Int. 2010 Jan; 14(1):39-46.
Score: 0.003
-
Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8.
Score: 0.003
-
A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23.
Score: 0.003
-
Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol. 1989 Jul; 257(1 Pt 2):F99-106.
Score: 0.003
-
Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int. 1989 Jul; 36(1):108-13.
Score: 0.003
-
In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5.
Score: 0.003
-
Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am J Nephrol. 2009; 30(1):12-8.
Score: 0.003
-
The risks of oral contraceptives and estrogen replacement therapy. Perspect Biol Med. 1989; 33(1):86-106.
Score: 0.003
-
Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205.
Score: 0.003
-
A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71.
Score: 0.003
-
Prevalence of hyperoxaluria after bariatric surgery. J Urol. 2009 Jan; 181(1):161-6.
Score: 0.003
-
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
Score: 0.003
-
Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94.
Score: 0.003
-
Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
Score: 0.003
-
Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988 Jun; 33(6):1140-6.
Score: 0.003
-
Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9.
Score: 0.003
-
Pathophysiology of kidney stones and strategies for treatment. Hosp Pract (Off Ed). 1988 Mar 15; 23(3):185-9, 193-5, 199-200 passim.
Score: 0.003
-
Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34.
Score: 0.003
-
Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008 Mar; 28(2):111-9.
Score: 0.003
-
Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987 Nov; 32(5):749-53.
Score: 0.002
-
Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct; 290(10):1315-23.
Score: 0.002
-
Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11.
Score: 0.002
-
Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. J Clin Invest. 1987 Jun; 79(6):1782-7.
Score: 0.002
-
The pathogenesis of calyceal diverticular calculi. Urol Res. 2007 Feb; 35(1):35-40.
Score: 0.002
-
Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801.
Score: 0.002
-
Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab. 1987; 13(4):267-72.
Score: 0.002
-
The role of Randall's plaques in the pathogenesis of calcium stones. J Urol. 2007 Jan; 177(1):31-8.
Score: 0.002
-
A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90.
Score: 0.002
-
Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism? N Engl J Med. 1986 Jun 05; 314(23):1508-9.
Score: 0.002
-
Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest. 1986 Jun; 77(6):1888-96.
Score: 0.002
-
Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006 Jun; 97(6):1285-90.
Score: 0.002
-
Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35.
Score: 0.002
-
Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006 May; 175(5):1720-4; discussion 1724.
Score: 0.002
-
Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006 Apr; 69(8):1313-8.
Score: 0.002
-
Recurrent renal calculi. Causes and prevention. Hosp Pract (Off Ed). 1986 Mar 30; 21(3A):49-57.
Score: 0.002
-
Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int. 2006 Mar; 69(6):1041-7.
Score: 0.002
-
Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9.
Score: 0.002
-
Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct; 76(4):1455-62.
Score: 0.002
-
Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9.
Score: 0.002
-
Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9.
Score: 0.002
-
Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54.
Score: 0.002
-
Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91.
Score: 0.002
-
Hyperkalemia during acute ammonium chloride acidosis in man. Nephron. 1985; 40(1):38-40.
Score: 0.002
-
Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985; 11(4):267-9.
Score: 0.002
-
Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol. 2005 Jan; 173(1):117-9; discussion 119.
Score: 0.002
-
Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85.
Score: 0.002
-
Treatment of hypercalciuria. N Engl J Med. 1984 Jul 12; 311(2):116-8.
Score: 0.002
-
Pathophysiology of hypercalciuria. Am J Physiol. 1984 Jul; 247(1 Pt 2):F1-13.
Score: 0.002
-
Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria. J Pediatr. 1983 Dec; 103(6):932-5.
Score: 0.002
-
Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403.
Score: 0.002
-
Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar; 111(5):607-16.
Score: 0.002
-
Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003 Feb; 63(2):662-9.
Score: 0.002
-
Idiopathic hypercalciuria. Henry Ford Hosp Med J. 1983; 31(4):229-30.
Score: 0.002
-
Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int. 1982 Oct; 22(4):366-70.
Score: 0.002
-
Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med. 1982 Jan; 72(1):25-32.
Score: 0.002
-
Prevention of kidney stones. Am J Med. 1981 Oct; 71(4):514-6.
Score: 0.002
-
Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44.
Score: 0.002
-
Nephrolithiasis: causes, classification, and management. Hosp Pract (Hosp Ed). 1981 Apr; 16(4):33-45.
Score: 0.002
-
[Vitamin D physiology and its application to disorders of calcium metabolism]. Recenti Prog Med. 1981 Feb; 70(2):119-40.
Score: 0.002
-
Idiopathic hypercalciuria in calcium nephrolithiasis. Dis Mon. 1980 Sep; 26(12):1-36.
Score: 0.002
-
Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10.
Score: 0.001
-
Primary hyperparathyroidism and basal cell nevus syndrome. Ann Intern Med. 1980 Jul; 93(1):147.
Score: 0.001
-
Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med. 1980 Jul; 93(1):60-1.
Score: 0.001
-
Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980 May; 17(5):662-8.
Score: 0.001
-
Recurrence of renal stones. Lancet. 1980 Mar 22; 1(8169):651.
Score: 0.001
-
Does mild, asymptomatic hyperparathyroidism require surgery? N Engl J Med. 1980 Jan 24; 302(4):224-5.
Score: 0.001
-
Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease. Scand J Urol Nephrol Suppl. 1980; 53:171-7.
Score: 0.001
-
The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl. 1980; 53:265-71.
Score: 0.001
-
Treatment of renal calculi. Adv Intern Med. 1980; 26:373-92.
Score: 0.001
-
Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980; 128:439-50.
Score: 0.001
-
Familial idiopathic hypercalciuria. N Engl J Med. 1979 Feb 15; 300(7):337-40.
Score: 0.001
-
An inventory of our therapeutic possessions. Med Clin North Am. 1978 Nov; 62(6):1147-56.
Score: 0.001
-
Symposium on renal therapeutics. Foreword. Med Clin North Am. 1978 Nov; 62(6):1145.
Score: 0.001
-
Isolation and characterization of calcium oxalate crystal growth inhibitors from human urine. Biochem Biophys Res Commun. 1978 Oct 30; 84(4):1038-44.
Score: 0.001
-
Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3.
Score: 0.001
-
Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26.
Score: 0.001
-
Nephrolithiasis during pregnancy. N Engl J Med. 1978 Feb 09; 298(6):324-6.
Score: 0.001
-
Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998 Jan; 53(1):194-9.
Score: 0.001
-
Metabolic alkalosis. JAMA. 1977 Nov 21; 238(21):2288-90.
Score: 0.001
-
Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. Am J Physiol. 1977 Nov; 233(5):F455-63.
Score: 0.001
-
Metabolic acidosis after sulfur ingestion. N Engl J Med. 1977 Oct 20; 297(16):869-70.
Score: 0.001
-
The natural history of calcium urolithiasis. JAMA. 1977 Oct 03; 238(14):1519-23.
Score: 0.001
-
Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10.
Score: 0.001
-
Treatment of hypertension by computer and physician-a prospective controlled study. J Chronic Dis. 1977 Feb; 30(2):81-92.
Score: 0.001
-
The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976 Dec; 29(12):793-800.
Score: 0.001
-
Evidence for mild reversible hyperparathyroidism in distal renal tubular acidosis. Arch Intern Med. 1975 Nov; 135(11):1485-9.
Score: 0.001
-
Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man. Kidney Int. 1975 Oct; 8(4):263-73.
Score: 0.001
-
Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50.
Score: 0.001
-
Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch Intern Med. 1974 Aug; 134(2):262-5.
Score: 0.001
-
The performance of a computer system for metabolic assessment of patients with nephrolithiasis. Comput Biomed Res. 1974 Feb; 7(1):40-55.
Score: 0.001
-
Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31.
Score: 0.001
-
Chronic renal failure. Clin Symp. 1973; 25(1):2-32.
Score: 0.001
-
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest. 1973 Jan; 52(1):134-42.
Score: 0.001
-
Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary? Trans Assoc Am Physicians. 1971; 84:152-61.
Score: 0.001
-
A diagnostic approach to the patient with renal stones. Med Times. 1970 Oct; 98(10):87-94.
Score: 0.001
-
A new spectrophotometric method for measuring calcium oxalate monohydrate crystal aggregation in the absence of supersaturation: inhibitory effects of urinary glycoproteins. Urol Res. 1989; 17(3):149-50.
Score: 0.001
-
Nephrolithiasis and gestation. Baillieres Clin Obstet Gynaecol. 1987 Dec; 1(4):909-19.
Score: 0.001
-
Nephrolithiasis in pregnancy. Am J Kidney Dis. 1987 Apr; 9(4):354-8.
Score: 0.001
-
Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancer. Surgery. 1986 Sep; 100(3):494-9.
Score: 0.001
-
Dynamic clinical studies with radioisotopes and the scintillation camera. I. Sodium iodohippurate I-131 renography. JAMA. 1966 Jul 04; 197(1):15-24.
Score: 0.001
-
Immunochemistry of urinary calcium oxalate crystal growth inhibitor (CGI). Kidney Int. 1986 Apr; 29(4):829-33.
Score: 0.001
-
Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Physicians. 1985; 98:281-9.
Score: 0.001
-
Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem. 1983 Oct 25; 258(20):12594-600.
Score: 0.000
-
Arterial PCO2 in chronic metabolic acidosis. Kidney Int. 1982 Sep; 22(3):311-4.
Score: 0.000
-
Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med. 1982 May 06; 306(18):1088-91.
Score: 0.000
-
Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7.
Score: 0.000
-
Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24.
Score: 0.000
-
Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem. 1981 Apr 25; 256(8):3936-44.
Score: 0.000
-
Hyperparathyroidism in nephrolithiasis. Arch Intern Med. 1980 Nov; 140(11):1479-81.
Score: 0.000
-
Nutritional and metabolic complications in a patient with Crohn's disease and ileal resection. Gastroenterology. 1980 May; 78(5 Pt 1):1069-79.
Score: 0.000
-
Viomycin-induced electrolyte abnormalities. Respiration. 1980; 40(5):284-92.
Score: 0.000
-
Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb; 90(2):180-4.
Score: 0.000
-
Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10.
Score: 0.000
-
Maternal primary hyperparathyroidism of pregnancy. Successful treatment by parathyroidectomy. JAMA. 1977 Aug 08; 238(6):508-9.
Score: 0.000
-
Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med. 1974 May; 56(5):704-14.
Score: 0.000
-
Hemodialysis in children: technique, kinetic aspects related to varying body size, and application to salicylate intoxication, acute renal failure and some other disorders. Medicine (Baltimore). 1966 Jan; 45(1):1-50.
Score: 0.000